603127 Joinn Laboratories
- 14.04
- -0.13-0.92%
Joinn Laboratories News
Announcement of resolutions of 2023 annual general meeting of shareholders, 2024 second A-share category shareholders' meeting and 2024 second H-share category shareholders' meeting of Joinn Laboratories.
Legal opinion of Tianyuan Law Firm on the 2023 annual shareholders' meeting, 2024 second A-share category shareholder meeting and 2024 second listed in Hong Kong category shareholder meeting of Joinn Laboratories.
Announcement of the expiration of the shareholder shareholding reduction plan and the shareholding reduction results of Joinn Laboratories.
Joinn Laboratories announces the progress of repurchasing company A shares through centralized bidding trading.
Information on the 2023 Annual General Meeting of Shareholders of Zhaoyan Pharmaceutical, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024
Response from KPMG Huazhen Certified Public Accountants (Special General Partnership) on the questions requested from accountants in the inquiry letter for the 2023 annual report of Beijing Zhaoyan New Drug Research Center Co., Ltd.
Notice of Zhaoyan Pharmaceutical on holding the 2023 Annual General Meeting of Shareholders, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024
Announcement of Zhaoyan Pharmaceutical's response to the Shanghai Stock Exchange's letter on the information disclosure supervision of the company's 2023 annual report
Announcement of Zhaoyan Pharmaceutical on holding a performance briefing for the first quarter of 2024
Announcement of Zhaoyan Pharmaceutical's Notice to Creditors on Repurchase and Cancellation of Some Restricted Shares
Zhaoyan Pharmaceutical's progress announcement on cooperation with professional investment institutions to participate in the establishment of industrial funds and related transactions
Announcement of Zhaoyan Pharmaceutical on the initial repurchase of the company's A-share shares through centralized bidding transactions and the progress of the repurchase
Zhaoyan New Pharmaceutical 2024 First Quarter Report
Zhaoyan Pharmaceutical's progress announcement on cooperation with professional investment institutions to participate in the establishment of industrial funds and related transactions
H Shares Announcement: Notice of Board Meeting
Beijing Zhaoyan New Drug Research Center Co., Ltd. Supplementary Explanatory Notice on Daily Continued Related Transactions
Announcement of Zhaoyan Pharmaceutical on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for the repurchase of A-shares
Announcement of Zhaoyan New Pharmaceutical on holding the 2023 Annual Results Briefing
Zhaoyan Pharmaceutical's announcement on the progress of repurchasing the company's A-share shares through centralized bidding transactions
Working Rules for the Audit Committee of the Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd. (March 2024)
Analysis
Price Target
No Data
